Stonington Institute

Stonington Institute

Services:
Type of Alcohol Use Disorder Treatment
• This facility administers/prescribes medication for alcohol use disorder
• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere

Type of Opioid Treatment

• Buprenorphine maintenance
• Accepts clients using MAT but prescribed elsewhere
• Buprenorphine detoxification
• Prescribes buprenorphine
• Prescribes naltrexone
• Lofexidine or Clonidine detoxification
• Relapse prevention with naltrexone

Testing

• Breathalyzer or blood alcohol testing
• Testing for Hepatitis B (HBV)
• Drug or alcohol urine screening
• HIV testing
• TB screening
• Testing for Hepatitis C (HCV)

Age Groups Accepted

• Adults
• Young Adults

External Source of Medications Used for Alcohol Use Disorder Treatment

• Other contracted prescribing entity

Transitional Services

• Naloxone and overdose education
• Outcome follow-up after discharge
• Aftercare/continuing care
• Discharge Planning

Recovery Support Services

• Assistance with obtaining social services
• Housing services
• Self-help groups
• Employment counseling or training

Type of Care

• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
• Substance use treatment
• Detoxification

Detoxification (medical withdrawal) Services

• Medication routinely used during detoxification
• Opioids detoxification
• Alcohol Detoxification
• Benzodiazepines Detoxification
• Cocaine Detoxification

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Residential detoxification
• Short-term residential
• Residential/24-hour residential

Ancillary Services

• Case management service
• Suicide prevention services
• Mental health services
• Social skills development
• Transportation assistance

License/Certification/Accreditation

• The Joint Commission
• State department of health
• Drug Enforcement Agency (DEA)

Facility Operation (e.g., Private, Public)

• Private for-profit organization

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

Facility Vaping Policy

• Vaping permitted in designated area

External Opioid Medications Source

• No formal relationship with prescribing entity

Pharmacotherapies

• Clonidine
• Non-nicotine smoking/tobacco cessation
• Medication for mental disorders
• Naltrexone (oral)
• Nicotine replacement
• Disulfiram
• Buprenorphine with naloxone
• Naltrexone (extended-release, injectable)

Gender Accepted

• Female
• Male

Payment/Insurance/Funding Accepted

• Private health insurance
• State-financed health insurance plan other than Medicaid
• Medicaid
• Cash or self-payment
• Federal military insurance (e.g., TRICARE)

Education and Counseling Services

• Group counseling
• Marital/couples counseling
• Individual counseling
• Health education services other than HIV/AIDS or hepatitis
• Substance use disorder education
• Smoking/vaping/tobacco cessation counseling
• Family counseling

Treatment Approaches

• Relapse prevention
• Anger management
• Brief intervention
• Trauma-related counseling
• Cognitive behavioral therapy
• Substance use disorder counseling
• 12-step facilitation
• Motivational interviewing

Facility Smoking Policy

• Smoking permitted in designated area

Language Services

• Sign language services for the deaf and hard of hearing

Special Programs/Groups Offered

• Pregnant/postpartum women
• Clients with HIV or AIDS
• Adult women
• Veterans
• Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
• Members of military families
• Active duty military
• Seniors or older adults
• Clients with co-occurring pain and substance use disorders
• Clients with co-occurring mental and substance use disorders
• Clients who have experienced trauma
• Adult men

Assessment/Pre-treatment

• Complete medical history/physical exam
• Comprehensive mental health assessment
• Comprehensive substance use assessment
• Screening for mental disorders
• Screening for substance use
• Screening for tobacco use